AEON Biopharma, Inc. — Director's Dealing 2021

Feb 9, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Priveterra Acquisition Corp. (PMGM)
CIK: 0001837607
Period of Report: 2021-02-08

Reporting Person: Priveterra Sponsor, LLC (Director, 10% Owner)
Reporting Person: PALMISANO ROBERT J (Director, CEO, 10% Owner)
Reporting Person: Malik Vikram (Director, President, 10% Owner)
Reporting Person: Grodnensky Oleg (Director, COO and CFO, 10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Common Stock	$		Class A Common Stock (6900000)		Direct

Footnotes

F1: The shares of Class B common stock are convertible for shares of the Issuer's Class A common stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-252310) (the "Registration Statement") and have no expiration date. The shares of Class B common stock beneficially owned by the Reporting Persons include up to 900,000 shares of Class B common stock subject to forfeiture to the Issuer depending on the extent to which the underwriters' over-allotment option is exercised in connection with the Issuer's initial public offering of units, as described in the Registration Statement.

F2: Priveterra Sponsor, LLC is the record holder of the securities reported herein. Messrs Palmisano, Malik and Grodnensky are the managers of Priveterra Sponsor, LLC and share voting and investment discretion with respect to the securities held of record by Priveterra Sponsor, LLC.

F3: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.